Intelligent Antibody Discovery

Therapeutic monoclonal antibodies for medicine

Abeome is a privately-held antibody discovery company focused on the high-throughput selection, analysis and synthesis of monoclonal antibodies with a primary objective to develop best-in-class prescription products for the therapeutic antibody market – the fastest growing segment of global drug sales.

Read More »

Recent News

Abeome Launches New Website and Brand Refresh

Abeome announces a new website and brand refresh.

Abeome Receives Grant for AbeoMouse™ Technology

Abeome Corporation announced today the receipt of an award letter for a Small Business Innovative Research (SBIR) grant in the amount of $217,860 over 10 months.